+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Ambulatory Cardiac Monitoring Market Outlook 2026-2034: by Device Type (ECG Devices, Event Recorders, Implantable Cardiac Loop Recorders, Mobile Cardiac Telemetry, Others), Indication, Service Provider, End-User

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6244072
UP TO OFF until Jan 01st 2027
The Ambulatory Cardiac Monitoring Market is estimated at US$15.5 billion in 2026 and is projected to grow at a CAGR of 49.8% to reach US$393 billion by 2034.

Market Overview

The ambulatory cardiac monitoring market includes wearable and portable monitoring systems used outside acute care settings to detect rhythm abnormalities and support long-duration cardiac observation. The value chain covers electronic component sourcing, patch and recorder assembly, software analytics, physician review networks, distributor channels, and remote monitoring services.

Key end uses include arrhythmia detection, post-discharge surveillance, symptom correlation, preventive cardiology, and remote cardiac management. At the same time, the market faces challenges related to data overload, reimbursement complexity, patient adherence, and strong expectations around accuracy and clinical validation.

Market Segmentation

By Device Type

  • ECG Devices
  • Event Recorders
  • Implantable Cardiac Loop Recorders
  • Mobile Cardiac Telemetry
  • Others

By Indication

  • Atrial Fibrillation
  • Unexplained Syncope
  • Other Arrhythmias

By Service Provider

  • Independent Diagnostic Testing Facilities (IDTFs)
  • OEM Remote Monitoring Services
  • Hospital-based Monitoring Services

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Other End-Users

Key Companies Analysed

  • iRhythm Technologies, Inc.
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • Medtronic plc
  • Abbott Laboratories
  • Baxter International Inc.
  • BioTelemetry, Inc.
  • Hill-Rom Holdings, Inc.
  • Cardiac Insight, Inc.
  • Preventice Solutions, Inc.
  • AliveCor, Inc.
  • Bittium Corporation
  • Biotricity Inc.
  • ACS Diagnostics, Inc.
  • Medicomp Inc.
  • ScottCare Corporation
  • Nihon Kohden Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • InfoBionic, Inc.

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Ambulatory Cardiac Monitoring Market Overview
2.1. Ambulatory Cardiac Monitoring Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Ambulatory Cardiac Monitoring Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Ambulatory Cardiac Monitoring Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Ambulatory Cardiac Monitoring Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. Ambulatory Cardiac Monitoring Market Analysis By Device Type, 2025-2034
5.2.1. ECG Devices
5.2.2. Event Recorders
5.2.3. Implantable Cardiac Loop Recorders
5.2.4. Mobile Cardiac Telemetry
5.2.5. Others
5.3. Ambulatory Cardiac Monitoring Market Analysis By Indication, 2025-2034
5.3.1. Atrial Fibrillation
5.3.2. Unexplained Syncope
5.3.3. Other Arrhythmias
5.4. Ambulatory Cardiac Monitoring Market Analysis By Service Provider, 2025-2034
5.4.1. Independent Diagnostic Testing Facilities (IDTFs)
5.4.2. OEM Remote Monitoring Services
5.4.3. Hospital-based Monitoring Services
5.5. Ambulatory Cardiac Monitoring Market Analysis By End-User, 2025-2034
5.5.1. Hospitals
5.5.2. Ambulatory Surgical Centers
5.5.3. Homecare Settings
5.5.4. Other End-Users
6. North America Ambulatory Cardiac Monitoring Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Ambulatory Cardiac Monitoring Market Analysis By Device Type
6.3. North America Ambulatory Cardiac Monitoring Market Analysis By Indication
6.4. North America Ambulatory Cardiac Monitoring Market Analysis By Service Provider
6.5. North America Ambulatory Cardiac Monitoring Market Analysis By End-User
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe Ambulatory Cardiac Monitoring Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Ambulatory Cardiac Monitoring Market Analysis By Device Type
7.3. Europe Ambulatory Cardiac Monitoring Market Analysis By Indication
7.4. Europe Ambulatory Cardiac Monitoring Market Analysis By Service Provider
7.5. Europe Ambulatory Cardiac Monitoring Market Analysis By End-User
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific Ambulatory Cardiac Monitoring Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Ambulatory Cardiac Monitoring Market Analysis By Device Type
8.3. Asia-Pacific Ambulatory Cardiac Monitoring Market Analysis By Indication
8.4. Asia-Pacific Ambulatory Cardiac Monitoring Market Analysis By Service Provider
8.5. Asia-Pacific Ambulatory Cardiac Monitoring Market Analysis By End-User
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa Ambulatory Cardiac Monitoring Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Ambulatory Cardiac Monitoring Market Analysis By Device Type
9.3. Middle East and Africa Ambulatory Cardiac Monitoring Market Analysis By Indication
9.4. Middle East and Africa Ambulatory Cardiac Monitoring Market Analysis By Service Provider
9.5. Middle East and Africa Ambulatory Cardiac Monitoring Market Analysis By End-User
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America Ambulatory Cardiac Monitoring Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Ambulatory Cardiac Monitoring Market Analysis By Device Type
10.3. South and Central America Ambulatory Cardiac Monitoring Market Analysis By Indication
10.4. South and Central America Ambulatory Cardiac Monitoring Market Analysis By Service Provider
10.5. South and Central America Ambulatory Cardiac Monitoring Market Analysis By End-User
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. Ambulatory Cardiac Monitoring Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. iRhythm Technologies, Inc.
11.2.2. Boston Scientific Corporation
11.2.3. Koninklijke Philips N.V.
11.2.4. GE HealthCare Technologies Inc.
11.2.5. Medtronic plc
11.2.6. Abbott Laboratories
11.2.7. Baxter International Inc.
11.2.8. BioTelemetry, Inc.
11.2.9. Hill-Rom Holdings, Inc.
11.2.10. Cardiac Insight, Inc.
11.2.11. Preventice Solutions, Inc.
11.2.12. AliveCor, Inc.
11.2.13. Bittium Corporation
11.2.14. Biotricity Inc.
11.2.15. ACS Diagnostics, Inc.
11.2.16. Medicomp Inc.
11.2.17. ScottCare Corporation
11.2.18. Nihon Kohden Corporation
11.2.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.2.20. InfoBionic, Inc.
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • iRhythm Technologies, Inc.
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • Medtronic plc
  • Abbott Laboratories
  • Baxter International Inc.
  • BioTelemetry, Inc.
  • Hill-Rom Holdings, Inc.
  • Cardiac Insight, Inc.
  • Preventice Solutions, Inc.
  • AliveCor, Inc.
  • Bittium Corporation
  • Biotricity Inc.
  • ACS Diagnostics, Inc.
  • Medicomp Inc.
  • ScottCare Corporation
  • Nihon Kohden Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • InfoBionic, Inc.

Table Information